Picture of Microbix Biosystems logo

MBX — Microbix Biosystems News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Microbix Says Q4 Revenue Rose 6% To C$3.587 Million

Dec 20 (Reuters) - Microbix Biosystems Inc  MBX.TO :
    * MICROBIX REPORTS RESULTS FOR FISCAL 2019
    * Q4 REVENUE ROSE 6 PERCENT TO C$3.587 MILLION
    * QTRLY LOSS PER SHARE $0.001
    * MICROBIX BIOSYSTEMS - FOR FISCAL 2020, CO WILL WORK TO
CONTINUE
IMPROVING PERCENTAGE GROSS MARGINS FROM ITS CRITICAL INGREDIENTS
BUSINESS
    * MICROBIX BIOSYSTEMS - WORK CONTINUES WITH REGARDS TO
SECURING
PARTNERSHIP AGREEMENT TO ADVANCE MICROBIX'S KINLYTIC UROKINASE
PROJECT

Source text for Eikon:  ID:nGNXFZ1wC 
Further company coverage:  MBX.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Microbix Biosystems

See all news